Apr 19 |
XBI: 3 Reasons To Buy The Pullback And Hold This Biotech ETF Forever
|
Apr 7 |
Morgan Stanley sees Fed rate cut fueling biotech stocks
|
Apr 4 |
Clean Energy, Semiconductors Among Interest-Rate-Sensitive Sectors Hammered Thursday Afternoon On Rate Cut Concerns
|
Mar 20 |
XBI: Biotech Is A Strong Buy As M&A Activity Picks Up (Rating Upgrade)
|
Feb 28 |
Chart Advisor: Rising Trends Within Biotechnology
|
Feb 19 |
Healthcare dealmakers see increased M&A, valuations in 2024: KPMG
|
Feb 15 |
Top 10 ETFs have the lowest weighted average free cash flow yield - GS
|
Jan 28 |
THQ Vs. XBI: Keeping The Biotech ETF For Now
|
Jan 23 |
XBI: Biotech Speculation
|
Jan 18 |
Healthcare In 2024: Navigating The Biopharma Bull Run
|